article thumbnail

A history of blood cancer treatment

pharmaphorum

It wasn’t until 2002, when Memorial Sloane Kettering Cancer Center scientists Michel Sadelain, Renier Brentjens, and Isabelle Rivière opted to push the boundaries of research, by genetically engineering T-cells with a CAR, that the technique achieved successful results. 2012 – The 100,000 Genomics Project begins.